Benjamin DAMIEN
CEO
SAGITTA BIOTECH
Liège, Liège, Belgium
14 profile visitsSpeakerFlanders Vaccine/BioWin member
Ben is active in Tech SMEs for 22 years (as CEO, Head of BD, COO, etc). Ben has a PhD in Immunology, and a MBA from Solvay Business School.
My organisation
Sagitta Biotech is developing innovative therapies against infectious diseases and cancer based on its viral vector/mRNA platform.
The technology allows us to develop very quickly vaccines that are safe and effective, but also to manufacture them at a very low cost (cents per dose) thanks to a "constant manufacturing process" (identical for all vaccines).
This allows us to get significant shortcuts during development, and reduce the cost of operations for our customers.
About me
Phd in Immunology and MBA from Solvay.
Managing Biotech companies since 2003.
Skills
- vaccines
- Immunology
- oncology
- Molecular Biology
- Management
- corporate funding
Interests
- Funding
- deal making
- startups
Speaker sessions (1)
Thursday, 12 June 2025
14:30 - 15:15
Pitch session
Location:Erasmus 1
Speaker presentation
Download speaker presentation